Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. (Q54240868)

26 May 2018

title

Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. (English)

1 reference

26 May 2018

main subject

pulmonary hypertension

1 reference

Zayek M

1

1 reference

26 May 2018

Cleveland D

series ordinal

2

1 reference

26 May 2018

Morin FC 3rd

series ordinal

3

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 May 1993

1 reference

26 May 2018

The Journal of Pediatrics

published in

1 reference

26 May 2018

volume

122

1 reference

26 May 2018

issue

5 Pt 1

1 reference

26 May 2018

page(s)

743-750

1 reference

26 May 2018

Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Refractory hypoxemia associated with neonatal pulmonary disease: The use and limitations of tolazoline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Persistent pulmonary hypertension in the neonate: Diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Hemodynamic effects of pulmonary arterial infusion of vasodilators in newborn lambs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Pulmonary hemodynamics in fetal lambs during development at normal and increased oxygen tension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Serum salicylate levels and right-to-left ductus shunts in newborn infants with persistent pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Hyperventilation, alkalosis, prostaglandins, and pulmonary circulation of the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

A kinetic study on functional impairment of nitric oxide-exposed rat erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Oxidation of nitrogen oxides by bound dioxygen in hemoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Endothelium-derived relaxing factor: presence in pulmonary and systemic arteries of the newborn guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Pulmonary vasodilation with structurally altered pulmonary vessels and pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980020-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(06)80020-X

1 reference

26 May 2018

PubMed ID

8496755

1 reference

26 May 2018